Regeneron Pharmaceuticals has grown revenue 7.0% a year over three years and 4.6% a year over five, with earnings per share compounding at 2.3%. Revenue growth, 3-year annual rate: +7.0% (Biotechnology median +21%). Revenue growth, 5-year rate: +4.6%, growth has picked up over the last three years. Earnings per share, 3-year rate: +2.3%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 18, FY2008 to FY2025, as filed.

REGNRegeneron Pharmaceuticals

HealthcareUSD

$814.96

$542.9652 weeks$841.24

Is it growing?

Is REGN growing?

Regeneron Pharmaceuticals has grown revenue 7.0% a year over three years and 4.6% a year over five, with earnings per share compounding at 2.3%.

+7.0%

Revenue growth, 3-year annual rate · Biotechnology median +21% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +4.6%
Revenue growth, 5-year rate · +7.0% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +2.3%
Earnings per share, 3-year rate · revenue +7.0% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed